1
|
Spindler L, Etienney I, Abramowitz L, de Parades V, Pigot F, Siproudhis L, Adam J, Balzano V, Bouchard D, Bouta N, Bucau M, Carlo A, Chanal J, Charpentier C, Clifford G, Draullette M, Fathallah N, Ferré V, Fléjou JF, Fouéré S, Higuero T, Kassouri L, Kurt S, Laurain A, Leclerc E, Lepiller Q, Lesage AC, Mège D, Ménard A, Merle P, Mortreux P, Noël C, Péré H, Prétet JL, Roland D, Staumont G, Tracanelli L, Vuitton L, Wylomanski S, Zaegel-Faucher O. Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practice. Tech Coloproctol 2024; 28:23. [PMID: 38198036 PMCID: PMC10781838 DOI: 10.1007/s10151-023-02899-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/14/2023] [Accepted: 12/01/2023] [Indexed: 01/11/2024]
Abstract
In France, about 2000 new cases of anal cancer are diagnosed annually. Squamous cell carcinoma is the most common histological type, mostly occurring secondary to persistent HPV16 infection. Invasive cancer is preceded by precancerous lesions. In addition to patients with a personal history of precancerous lesions and anal cancer, three groups are at very high risk of anal cancer: (i) men who have sex with men and are living with HIV, (ii) women with a history of high-grade squamous intraepithelial lesions (HSILs) or vulvar HPV cancer, and (iii) women who received a solid organ transplant more than 10 years ago. The purpose of screening is to detect HSILs so that they can be treated, thereby reducing the risk of progression to cancer. All patients with symptoms should undergo a proctological examination including standard anoscopy. For asymptomatic patients at risk, an initial HPV16 test makes it possible to target patients at risk of HSILs likely to progress to cancer. Anal cytology is a sensitive test for HSIL detection. Its sensitivity is greater than 80% and exceeds that of proctological examination with standard anoscopy. It is indicated in the event of a positive HPV16 test. In the presence of cytological abnormalities and/or lesions and a suspicion of dysplasia on clinical examination, high-resolution anoscopy is indicated. Performance is superior to that of proctological examination with standard anoscopy. However, this technique is not widely available, which limits its use. If high-resolution anoscopy is not possible, screening by a standard proctological examination is an alternative. There is a need to develop high-resolution anoscopy and triage tests and to evaluate screening strategies.
Collapse
Affiliation(s)
- L Spindler
- Service de Proctologie, Groupe Hospitalier Paris Saint-Joseph, Paris, France.
| | - I Etienney
- Service de Proctologie, Hôpital Diaconesses-Croix Saint Simon, Paris, France
| | - L Abramowitz
- Service de Proctologie, APHP Hôpital Bichat-Claude Bernard and Ramsay GDS Clinique Blomet, Paris, France
| | - V de Parades
- Service de Proctologie, Groupe Hospitalier Paris Saint-Joseph, Paris, France
| | - F Pigot
- Service de Proctologie, Hôpital Bagatelle, Talence, France
| | - L Siproudhis
- Service d'Hépato-Gastroentérologie, CHU Pontchaillou, Rennes, France
| | - J Adam
- Service d'Anatomopathologie, Groupe Hospitalier Paris Saint-Joseph, Paris, France
| | - V Balzano
- Service de Gastroentérologie et Oncologie Digestive, CHU Tours, Tours, France
| | - D Bouchard
- Service de Proctologie, Hôpital Bagatelle, Talence, France
| | - N Bouta
- Service d'Hépato-Gastroentérologie et de Proctologie, Clinique La Croix du Sud, Quint-Fonsegrives, France
| | - M Bucau
- Service d'Anatomopathologie, AP-HP Hôpital Bichat-Claude Bernard, Paris, France
| | - A Carlo
- Service d'Hépato-Gastroentérologie, CHU Pontchaillou, Rennes, France
| | - J Chanal
- Service de Dermatologie, AP-HP, Hôpital Tarnier, Paris, France
| | - C Charpentier
- Département de Virologie, AP-HP, Hôpital Bichat-Claude Bernard, INSERM, IAME, Université de Paris, Paris, France
| | - G Clifford
- Early Detection, Prevention, and Infections Branch, International Agency for Research On Cancer, Lyon, France
| | - M Draullette
- Service d'Hépato-Gastroentérologie et Assistance Nutritive, AP-HP, Hôpital Beaujon, Clichy, France
| | - N Fathallah
- Service de Proctologie, Groupe Hospitalier Paris Saint-Joseph, Paris, France
| | - V Ferré
- Département de Virologie, AP-HP, Hôpital Bichat-Claude Bernard, INSERM, IAME, Université de Paris, Paris, France
| | - J-F Fléjou
- Service d'Anatomopathologie, Cerbapath, Paris, France
| | - S Fouéré
- Service de Dermatologie, AP-HP, Hôpital Saint-Louis, Université de Paris, Paris, France
- Centre des Maladies Sexuellement Transmises, AP-HP, Hôpital Saint-Louis, Paris, France
| | - T Higuero
- Gastro-entérologue, proctologue medico-chirurgical, Beausoleil, France
| | - L Kassouri
- Service de Proctologie, Groupe Hospitalier Paris Saint-Joseph, Paris, France
| | - S Kurt
- Service de Proctologie, Groupe Hospitalier Paris Saint-Joseph, Paris, France
| | - A Laurain
- Service de Proctologie, APHP Hôpital Bichat-Claude Bernard and Ramsay GDS Clinique Blomet, Paris, France
| | - E Leclerc
- Service d'Hépato-Gastroentérologie, CHU Clermont-Ferrand, Inserm, 3iHP, Université Clermont Auvergne, Clermont-Ferrand, France
| | - Q Lepiller
- Laboratoire de Virologie, CHU de Besançon, Besançon, France
| | - A-C Lesage
- Service de Proctologie, Hôpital Diaconesses-Croix Saint Simon, Paris, France
| | - D Mège
- Service de Chirurgie Digestive, Université d'Aix Marseille, AP-HM, Hôpital de la Timone, Marseille, France
| | - A Ménard
- Institut Hospitalo-Universitaire Méditerranée Infection, AP-HM, Hôpital Nord, Université d'Aix Marseille, Marseille, France
| | - P Merle
- Service d'Hépato-Gastroentérologie et de Proctologie, Clinique La Croix du Sud, Quint-Fonsegrives, France
| | - P Mortreux
- Service de Gastroentérologie, Centre Hospitalier de Bethune Beuvry, Beuvry, France
| | - C Noël
- Service d'Hépato-Gastroentérologie, CHU de Brest, Brest, France
| | - H Péré
- Laboratoire de Virologie, Service de Microbiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, France
- Functional Genomics of Solid Tumors (FunGeST), Centre de Recherche des Cordelier, INSERM, Université de Paris, Sorbonne Université, Paris, France
| | - J-L Prétet
- EA3181, Université de Franche-Comté, LabEx LipSTIC ANR-11-LABX-0021, Besançon, France
- Centre National de Référence Papillomavirus, CHU de Besançon, Besançon, France
| | - D Roland
- Service de Proctologie, Groupe Hospitalier Paris Saint-Joseph, Paris, France
| | - G Staumont
- Service d'Hépato-Gastroentérologie et de Proctologie, Clinique La Croix du Sud, Quint-Fonsegrives, France
| | - L Tracanelli
- Service de Proctologie, Hôpital Bagatelle, Talence, France
| | - L Vuitton
- Service de Gastroentérologie, CHU de Besançon, Université de Bourgogne Franche-Comté, Besançon, France
| | - S Wylomanski
- Service de Gynécologie, Groupe Hospitalier Paris Saint-Joseph, Paris, France
| | - O Zaegel-Faucher
- Service d'Immuno-Hématologie Clinique, AP-HM, CHU Sainte-Marguerite, Marseille, France
| |
Collapse
|
2
|
Noël C, Sayegh S, Pitsch A, Depontfarcy A, Rouyer M, Matta M, Diamantis S. Infection nosocomiale et clusters intra hospitalier d'infection à SARS cov 2 dans un centre hospitalier Général : Bilan d'une année de pandémie. MÉDECINE ET MALADIES INFECTIEUSES FORMATION 2022. [PMCID: PMC9152509 DOI: 10.1016/j.mmifmc.2022.03.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Introduction La mise à disposition large des tests PCR SARS cov2 et la stratégie de dépistage systématique autour d'un cas a permis de mettre en évidence la survenue de transmissions croisées entrainant des infections nosocomiales au sein des services de soins. Un cluster est défini par la présence d'au moins 3 cas dans un service de soins dans un délai de 14 jours. L'objectif de l'étude est de définir le nombre de cas d'infection nosocomiale et de phénomène de cluster hospitalier aux décours de la 2ème et 3ème vague d'infection à SARS cov 2 dans un centre hospitalier Général. Matériels et méthodes Etude rétrospective des infections nosocomiales et des clusters intra hospitalier entre avril 2020 et avril 2021 L'infection nosocomiale est définie par la négativité d'une PCR d'entrée et la positivité d'une PCR à plus de 7 jours de l'entrée. Un cluster est défini par au moins trois cas d'infection nosocomiale dans une même unité de lieux et de temps (14jours). La deuxième vague comprend les cas identifiés entre les mois d'octobre et décembre 2020 et janvier avril 2021 pour la troisième. Résultats Quatre mille deux cents cinq PCR positives ont été détectées entre avril 2020 et avril 2021. Le nombre covid nosocomiaux était de 123 des 1654 patients hospitalisés (7.4 %) et ayant un diagnostic virologique d'infection à SARScov2. Cent onze (79 %) des cas nosocomiaux étaient liés à des clusters. Durant la deuxième vague, 14 clusters ont été détectés dans 8 services différents (moyenne de 5 patients par épisodes avec au minimum 3 et au maximum 18 patients par cluster). Pendant la troisième vague, 4 clusters ont été identifiés dans 4 services. La durée moyenne de résolution des clusters a été de 14 jours. Les clusters ont été détectés pour 58 cas (47 %)en secteur médecine chirurgie obstétrique et pour 65 (53 %) cas en secteur soins de suite et rééducation. La moyenne d'âge des cas nosocomiaux était de 83 ans, 85,37 % présentaient au moins une comorbidité et la mortalité a été de 22,76 % contre 19 % pour les cas communautaire (Xhi2 = 1.03 NS). Conclusion L'acquisition nosocomiale du virus SARS cov 2 a été est un phénomène bien réel entrainant une surmortalité en milieu hospitalier. Ces données patients permettent de justifier les mesures spécifiques comme la vaccination précoce et obligatoire des personnels soignants et des patients à risque, un renforcement des mesures d'hygiène et un contrôle des visites. Aucun lien d'intérêt
Collapse
|
3
|
De Filippis R, Almeida D, Cikrikcili U, Di Lodovico L, Filip M, Fusar-Poli L, Gürcan A, Gurrea Salas D, Mieze K, Mijaljica G, Noël C, Nwaubani P, Pantic M, Pérez Longás B, Pushko A, Román-Jarrín A, Santos M, Silagadze K, Sorokin M, Tapoi C, Hanon C, Hoertel N, Raballo A, Sartorius N, Pinto Da Costa M. Psychiatry training goes virtual: the experience of the first online edition of the EPA Research Summer School. Eur Psychiatry 2022. [PMCID: PMC9568213 DOI: 10.1192/j.eurpsy.2022.2192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Introduction
The European Psychiatric Association (EPA) Summer School allows psychiatric trainees and early career psychiatrists (ECPs) from all over Europe to meet, network, and learn together. After the 2020 edition being cancelled due to COVID-19, the 10th edition in 2021 focused for the first time on research and was conducted remotely.
Objectives
To provide an overview and feedback about the first Virtual EPA Research Summer School as a new way to encourage international networking during COVID-19.
Methods
The School was organized by the EPA Secretary for Education, and 4 Faculty members. It started with a “breaking the ice session” one week before and then a two-days meeting on 23-24 September 2021 using an online video-platform. This was preceded by all the 21 participants (from 18 different countries) recording a short 4-minute video presentation, which was uploaded and shared with other participants and Faculty.
Results
Participants were divided on a voluntary basis into three working groups: 1) “Drug repurposing: overcoming challenges in pharmacoepidemiology” 2) “Psychopathological research in psychiatry”; 3) “How to conduct a cross-sectional survey?”. The Summer School program was composed of plenary sessions with lectures by the Faculty members, discussion sessions, and working groups time. At the end, each group presented a summary of the work done to the rest of the participants.
Conclusions
Although the remote format limits social interactions during the Summer School, overall participants’ high satisfaction and productivity indicate that not only online formats, but also the topic of research might be covered in future editions.
Disclosure
No significant relationships.
Collapse
|
4
|
Tapoi C, De Filippis R, Noël C, Almeida D, Gurrea Salas D, Mieze K, Pushko A, Pinto Da Costa M. Making the most out of the EPA Research Summer School: from a group exercise to an international collaborative study protocol. Eur Psychiatry 2022. [PMCID: PMC9567916 DOI: 10.1192/j.eurpsy.2022.1953] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Introduction The 2021 Research Summer School took place virtually, and 7 psychiatric trainees or early career psychiatrists (ECPs) from 7 different European countries participated in a working group on how to conduct a cross-sectional survey study. Objectives To provide an overview of the process of developing an internationally collaborative protocol during the EPA Virtual Research Summer School. Methods All participants were asked by the Faculty mentor chairing this working group to write a research question that could be investigated through a cross-sectional survey. After a brainstorming discussion, it was decided to investigate the experiences, knowledge, and attitudes of psychiatric trainees and ECPs about electroconvulsive therapy (ECT) in Europe, an effective yet controversial procedure. Results The process of developing a protocol entailed different phases. First, a literature search was conducted, which supported the need to explore more the attitudes towards ECT among ECPs. Through group discussion the study’s objectives were decided, as well as the most appropriate methodology (including data collection and questionnaire use). At the end of the course, the core of the research plan was presented to all participants at the Research Summer School, preceding its implementation. Conclusions Participating in the EPA Research Summer School is a unique experience, a great learning opportunity, and can also lead to fruitful collaborations. It enabled the learning of the key aspects of designing and conducting a survey. In a short period of time, it was possible to design a study protocol for a future international cross-sectional survey on ECT. Disclosure No significant relationships.
Collapse
|
5
|
de Barbeyrac C, Roth P, Noël C, Anselem O, Gaudin A, Roumegoux C, Azcona B, Castel C, Noret M, Letamendia E, Stirnemann J, Ville Y, Lapillonne A, Viallard ML, Kermorvant-Duchemin E. The role of perinatal palliative care following prenatal diagnosis of major, incurable fetal anomalies: a multicentre prospective cohort study. BJOG 2021; 129:752-759. [PMID: 34665920 DOI: 10.1111/1471-0528.16976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/17/2021] [Indexed: 11/29/2022]
Abstract
OBJECTIVE To describe prenatal decision-making processes and birth plans in pregnancies amenable to planning perinatal palliative care. DESIGN Multicentre prospective observational study. SETTING Nine Multidisciplinary Centres for Prenatal Diagnosis of the Paris-Ile-de-France region. POPULATION All cases of major and incurable fetal anomaly eligible for TOP where limitation of life-sustaining treatments for the neonate was discussed in the prenatal period between 2015 and 2016. METHODS Cases of congenital defects amenable to perinatal palliative care were prospectively included in each centre. Prenatal diagnosis, decision-making process, type of birth plan, birth characteristics, pregnancy and neonatal outcome were collected prospectively and anonymously. MAIN OUTCOME MEASURE Final decision reached following discussions in the antenatal period. RESULTS We identified 736 continuing pregnancies with a diagnosis of a severe fetal condition eligible for TOP. Perinatal palliative care was considered in 102/736 (13.9%) pregnancies (106 infants); discussions were multidisciplinary in 99/106 (93.4%) cases. Prenatal birth plans involved life-sustaining treatment limitation and comfort care in 73/736 (9.9%) of the pregnancies. The main reason for planning palliative care at birth was short-term inevitable death in 39 cases (53.4%). In all, 76/106 (71.7%) infants were born alive, and 18/106 (17%) infants were alive at last follow-up, including four with a perinatal palliative care birth plan. CONCLUSIONS Only a small proportion of severe and incurable fetal disorders were potentially amenable to limitation of life-sustaining interventions. Perinatal palliative care may not be considered a universal alternative to termination of pregnancy. TWEETABLE ABSTRACT Perinatal palliative care is planned in 10% of continuing pregnancies with a major and incurable fetal condition eligible for TOP.
Collapse
Affiliation(s)
- C de Barbeyrac
- Department of Neonatal Medicine, AP-HP, Hôpital Necker-Enfants malades, Université de Paris, Paris, France
| | - P Roth
- Department Obstetrics and Fetal Medicine, AP-HP, Hôpital Necker-Enfants malades, Université de Paris, EA7328, Paris, France
| | - C Noël
- Department Obstetrics and Fetal Medicine, Centre Hospitalier René Dubos, Pontoise, France
| | - O Anselem
- Department of Department Obstetrics and Fetal Medicine, AP-HP, Hôpital Cochin - Port-Royal, Paris, France
| | - A Gaudin
- Department of Neonatal Medicine, AP-HP, Hôpital Robert-Debré, Paris, France
| | - C Roumegoux
- Department of Neonatal Medicine, AP-HP, Hôpital Jean-Verdier, Bondy, France
| | - B Azcona
- Department of Neonatal Medicine, Centre Hospitalier Intercommunal de Créteil, Créteil, France
| | - C Castel
- Department of Neonatal Medicine, Centre Hospitalier Intercommunal de Poissy-Saint-Quentin, Poissy, France
| | - M Noret
- Department of Obstetrics, AP-HP, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France
| | - E Letamendia
- Maternity Unit, AP-HP, Hôpital Antoine Béclère, Clamart, France
| | - J Stirnemann
- Department Obstetrics and Fetal Medicine, Centre Hospitalier René Dubos, Pontoise, France
| | - Y Ville
- Department Obstetrics and Fetal Medicine, Centre Hospitalier René Dubos, Pontoise, France
| | - A Lapillonne
- Department of Neonatal Medicine, AP-HP, Hôpital Necker-Enfants malades, Université de Paris, Paris, France
| | - M-L Viallard
- Palliative Medicine Unit, AP-HP, Hôpital Necker-Enfants malades, Université de Paris, Paris, France
| | - E Kermorvant-Duchemin
- Department of Neonatal Medicine, AP-HP, Hôpital Necker-Enfants malades, Université de Paris, Paris, France
| | | |
Collapse
|
6
|
Flateau C, Noël C, Bonnafoux A, Fuentes E, de Pontfarcy A, Diamantis S. Psychological impact of the SARS-CoV-2 outbreak on the staff of a French hospital. Infect Dis Now 2021; 51:187-193. [PMID: 33495766 PMCID: PMC7816966 DOI: 10.1016/j.idnow.2021.01.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2020] [Revised: 01/04/2021] [Accepted: 01/11/2021] [Indexed: 12/24/2022]
Abstract
Background The outbreak of SARS-CoV-2 has resulted in anxiety, depression and post-traumatic stress disorder (PTSD) among hospital staff. The factors associated with this psychological impact remain to be determined. Methods A cross-sectional study using an online questionnaire completed by the staff of a French hospital, two months after the SARS-CoV-2 outbreak. Results Among the 353 participants (of whom 67% were healthcare professionals), 32% had symptoms of anxiety, 16% of depression and 16% of PTSD. Eleven per cent had initiated or increased treatment with sleeping pills, and 6% with anxiolytics. In a multivariate analysis, factors independently associated with anxiety were: change of professional team, having a relative infected by SARS-CoV-2 and a new/increased treatment with sleeping pills or anxiolytics. The only factor associated with depression was the feeling of risk during professional practice. The factors associated with PTSD were: having a relative infected by SARS-CoV-2, the feeling of risk during professional practice, the increase in smoking and treatment with sleeping pills. The observance of transmission preventive measures (TPM) was not associated with the psychological impact of SARS-CoV-2. A personal history of SARS-CoV-2 infection and age < 36 years were associated with insufficient use of protective equipment. Age < 36 years, and being a healthcare professional were associated with the non-observance of social distancing. Conclusion The hospital staff displayed psychological consequences, resulting in the use of anxiolytics and sleeping pills. Belonging to a group with low-risk of severe disease was associated with lower observance of TPM.
Collapse
Affiliation(s)
- C Flateau
- Service des maladies infectieuses, Santépôle, groupe hospitalier Sud Île-de-France, 270, avenue Marc-Jacquet, 77000 Melun, France
| | - C Noël
- Équipe mobile opérationnelle d'hygiène, Santépôle, groupe hospitalier Sud Île-de-France, 270, avenue Marc-Jacquet, 77000 Melun, France
| | - A Bonnafoux
- Pôle médecine, Santépôle, groupe hospitalier Sud Île-de-France, 270, avenue Marc-Jacquet, 77000 Melun, France
| | - E Fuentes
- Pôle médecine, Santépôle, groupe hospitalier Sud Île-de-France, 270, avenue Marc-Jacquet, 77000 Melun, France
| | - A de Pontfarcy
- Service des maladies infectieuses, Santépôle, groupe hospitalier Sud Île-de-France, 270, avenue Marc-Jacquet, 77000 Melun, France
| | - S Diamantis
- Service des maladies infectieuses, Santépôle, groupe hospitalier Sud Île-de-France, 270, avenue Marc-Jacquet, 77000 Melun, France
| |
Collapse
|
7
|
Albert E, Noël C, Mathiaud C, Prochasson C, Raghu F, Lepvrier L, Peron P, Lucot C, Diamantis S, Vignier N. Efficacité d’une intervention de promotion et d’amélioration de l’accessibilité à la vaccination antigrippale pour les soignants d’un centre hospitalier général. Med Mal Infect 2020. [DOI: 10.1016/j.medmal.2020.06.388] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
8
|
Vendrely V, Amintas S, Noël C, Moranvillier I, Lamrissi I, Rousseau B, Coulibaly S, Bedel A, Moreau-Gaudry F, Buscail E, Chiche L, Belleannée G, Dupin C, Dabernat S. OC-0266 Pancreatic ductal adenocarcinoma sensitization to radiotherapy by bioactive food components. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30686-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
9
|
Maanaoui M, Lenain R, Hamroun A, Van Der Hauwaert C, Hennart B, Pottier N, Broly F, Noël C, Cauffiez C, Glowacki F. Impact du polymorphisme génétique de la caveolin-1 du donneur en transplantation rénale. Nephrol Ther 2018. [DOI: 10.1016/j.nephro.2018.07.381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
10
|
Roger C, Bui L, Gibier J, Gnemmi V, Hazzan M, Noël C. Une méthode diagnostique non invasive de néphropathie à cristaux biliaires. Nephrol Ther 2018. [DOI: 10.1016/j.nephro.2018.07.282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
11
|
Hamroun A, Bui L, Lenain R, Chamley P, Loridant S, Neugebauer Y, Lionet A, Noël C, Hazzan M. Hypercalcémie et pneumocystose chez le patient transplanté rénal : une association non fortuite ? Nephrol Ther 2018. [DOI: 10.1016/j.nephro.2018.07.397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
12
|
Van Triempont M, Bertrand D, Varlet P, Hazzan M, Lionet A, Noël C, Provôt F. Désimmunisation HLA chez des patients hyperimmunisés en transplantation rénale : l’expérience de deux centres français. Nephrol Ther 2018. [DOI: 10.1016/j.nephro.2018.07.369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
13
|
Maanaoui M, Provot F, Lionet A, Frimat M, Lebas C, Glowacki F, Noël C, Hazzan M. Pronostic de 116 greffes rénales issues de donneurs cadavériques de plus de 70 ans : une étude rétrospective et monocentrique. Nephrol Ther 2018. [DOI: 10.1016/j.nephro.2018.07.086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
14
|
Chamley P, Varlet P, Lionet A, Noël C, Hazzan M, Provôt F. Impact d’anticorps préformés anti-HLA-Cw et anti-HLA-DP spécifiques du donneur en transplantation rénale. Nephrol Ther 2018. [DOI: 10.1016/j.nephro.2018.07.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
15
|
Simphal P, Lionet A, Gibier J, Gnemmi V, Gomis S, Provôt F, Glowacki F, Lebas C, Noël C, Hazzan M. Y-a-t-il un intérêt à réaliser une ponction biopsie rénale protocolaire à 3 mois après transplantation rénale ? Nephrol Ther 2018. [DOI: 10.1016/j.nephro.2018.07.051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
16
|
Lemoine C, Vandenbussche C, Strecker A, Noël C, Hazzan M, Guincestre T. FP740PREHABILITATION BEFORE RENAL TRANSPLANTATION. Nephrol Dial Transplant 2018. [DOI: 10.1093/ndt/gfy104.fp740] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Cécile Lemoine
- Néphrologie et Médecine interne, Centre Hospitalier de Valenciennes, Valenciennes, France
| | - Cyrille Vandenbussche
- Néphrologie et Médecine interne, Centre Hospitalier de Valenciennes, Valenciennes, France
| | - Alain Strecker
- Soins de Suite et Réadaptation, Centre Hospitalier de Wattrelos, Wattrelos, France
| | - Christian Noël
- Néphrologie, Centre Hospitalier Universitaire de Lille, Lille, France
| | - Marc Hazzan
- Néphrologie, Centre Hospitalier Universitaire de Lille, Lille, France
| | | |
Collapse
|
17
|
Flamme-Obry F, Belaiche S, Hazzan M, Ramdan N, Noël C, Odou P, Décaudin B. [Clinical pharmacist and medication reconciliation in kidney transplantation]. Nephrol Ther 2018; 14:91-98. [PMID: 29477279 DOI: 10.1016/j.nephro.2017.04.004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2017] [Revised: 03/30/2017] [Accepted: 04/04/2017] [Indexed: 11/29/2022]
Abstract
INTRODUCTION Drug related problems (DRP) can lead to severe consequences in kidney recipients. The aim of the study was to assess the impact of the clinical pharmacist interventions on the incidence of DRP. METHOD The number of DRP were evaluated according to 3periods: Without intervention, with medication reconciliation at admission, and with medication reconciliation at admission associated with an interview with the clinical pharmacist at discharge. RESULTS Patients concerned were mainly men, 55years old (median age), stage3 of CKD, transplanted for less than 3months or more than 1year, with cardiovascular risk factors and receiving an average of 9drugs/day. Among the DRP, 20% were avoidable and severe in most cases. In period1, 27.7% patients had at least 1DRP, in period2, 21.3% patients had at least 1DRP, and in period3, 17.4% of patients had at least 1DRP (P=0.03). One hundred and ten patients had medication reconciliation at admission with a mean of 0.6unintentional discrepancies per patient (omission in 81% of cases). The main drugs involved concerned the digestive-metabolic (24.5%), cardiovascular (23%), and nervous (23%) system. Sixty-eight interviews at discharge were realized and revealed self-medication habits. CONCLUSION Our study shows that medication reconciliation at admission associated with an interview with the clinical pharmacist at discharge can help to reduce DRP in kidney recipients. Further studies are needed to confirm our results.
Collapse
Affiliation(s)
| | - Stéphanie Belaiche
- Institut de pharmacie, CHRU de Lille, rue Philippe-Marache, 59000 Lille, France; EA 7365, GRITA, groupe de recherche sur les formes injectables et les technologies associées, University Lille, 59000 Lille, France.
| | - Marc Hazzan
- Service de néphrologie, CHRU de Lille, 59000 Lille, France; Inserm U995, Lille Inflammation Research International Center (LIRIC), University Lille, 59000 Lille, France
| | - Nassima Ramdan
- EA 2694, santé publique : épidémiologie et qualité des soins, CHRU de Lille, University Lille, 59000 Lille, France
| | - Christian Noël
- Service de néphrologie, CHRU de Lille, 59000 Lille, France; Inserm U995, Lille Inflammation Research International Center (LIRIC), University Lille, 59000 Lille, France
| | - Pascal Odou
- Institut de pharmacie, CHRU de Lille, rue Philippe-Marache, 59000 Lille, France; EA 7365, GRITA, groupe de recherche sur les formes injectables et les technologies associées, University Lille, 59000 Lille, France
| | - Bertrand Décaudin
- Institut de pharmacie, CHRU de Lille, rue Philippe-Marache, 59000 Lille, France; EA 7365, GRITA, groupe de recherche sur les formes injectables et les technologies associées, University Lille, 59000 Lille, France
| |
Collapse
|
18
|
Susen S, Hazzan M, Labalette M, Zawadzki C, Dessaint J, Lelièvre G, Noël C, Jude B. Pentoxifylline Prevents Upregulation of Monocyte Tissue Factor in Renal Transplant Recipients Undergoing Post-graft Complications. Thromb Haemost 2017. [DOI: 10.1055/s-0037-1614112] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
SummaryPentoxifylline (PTX) has been demonstrated to improve graft survival in renal transplant recipients undergoing post graft complications. As activated monocytes are possible initiators of vascular damage through tissue factor (TF) expression, we evaluated the monocyte TF expression and endothelium activation markers in 140 consecutive patients receiving cadaveric kidney grafts, randomized in a double-blind study comparing PTX versus placebo. Monocyte TF expression and plasma von Willebrand factor, tissue plasminogen activator, thrombomodulin and tumor necrosis factor-α (TNF-α) levels were determined before transplantation and each month after. Additional samplings were realized in case of acute rejection. TF and TNF-α expression were significantly modified after graft. In patients with complications, PTX prevented the increase of TF expression at month one, and after rejection episodes. Endothelium activation markers were significantly modified after graft and in patients with complications but PTX had no significant effect on their plasma levels. These results suggest that the protective effect of PTX on graft survival could be related to the prevention of monocyte TF upregulation associated with complications.
Collapse
|
19
|
Perche J, Glowacki F, Samaille C, Deruelle P, Provot F, Hazzan M, Noël C, Frimat M. Grossesses menées sous anticalcineurines en transplantation rénale. Nephrol Ther 2017. [DOI: 10.1016/j.nephro.2017.08.033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
20
|
Faure E, Lionet A, Kipnis E, Noël C, Hazzan M. Risk factors for Pneumocystis
pneumonia after the first 6 months following renal transplantation. Transpl Infect Dis 2017; 19. [DOI: 10.1111/tid.12735] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2016] [Revised: 03/20/2017] [Accepted: 03/26/2017] [Indexed: 12/16/2022]
Affiliation(s)
- Emmanuel Faure
- Service de Néphrologie et Transplantation Rénale; CHRU de Lille; Lille France
| | - Arnaud Lionet
- Service de Néphrologie et Transplantation Rénale; CHRU de Lille; Lille France
| | - Eric Kipnis
- Réanimation Chirurgicale; CHRU de Lille; Lille France
| | - Christian Noël
- Service de Néphrologie et Transplantation Rénale; CHRU de Lille; Lille France
| | - Marc Hazzan
- Service de Néphrologie et Transplantation Rénale; CHRU de Lille; Lille France
| |
Collapse
|
21
|
Hazzan M, Frimat M, Glowacki F, Lionet A, Provot F, Noël C. [New scores in renal transplantation: How can we use them?]. Nephrol Ther 2017; 13 Suppl 1:S131-S136. [PMID: 28577735 DOI: 10.1016/j.nephro.2017.01.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2016] [Accepted: 01/08/2017] [Indexed: 11/17/2022]
Abstract
In renal transplant medicine, several scores have been recently developed in order to help decision-making in clinical practice. The aim of this update is to focus on these new scores that allow to better estimate the quality of the renal transplant, to refine the allocation policy, to help registration of old recipients on the waiting list, or to evaluate the risk to develop end-stage renal failure after living donation.
Collapse
Affiliation(s)
- Marc Hazzan
- Service de néphrologie, hôpital Huriez, CHRU de Lille, rue Michel-Polonowski, 59000 Lille, France; UMR 995, université de Lille, 59000 Lille, France.
| | - Marie Frimat
- Service de néphrologie, hôpital Huriez, CHRU de Lille, rue Michel-Polonowski, 59000 Lille, France; UMR 995, université de Lille, 59000 Lille, France
| | - François Glowacki
- Service de néphrologie, hôpital Huriez, CHRU de Lille, rue Michel-Polonowski, 59000 Lille, France
| | - Arnaud Lionet
- Service de néphrologie, hôpital Huriez, CHRU de Lille, rue Michel-Polonowski, 59000 Lille, France
| | - François Provot
- Service de néphrologie, hôpital Huriez, CHRU de Lille, rue Michel-Polonowski, 59000 Lille, France
| | - Christian Noël
- Service de néphrologie, hôpital Huriez, CHRU de Lille, rue Michel-Polonowski, 59000 Lille, France; UMR 995, université de Lille, 59000 Lille, France
| |
Collapse
|
22
|
Maanaoui M, Saint-Jacques C, Gnemmi V, Frimat M, Lionet A, Hazzan M, Noël C, Provot F. Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma: A case report. Medicine (Baltimore) 2017; 96:e7196. [PMID: 28640105 PMCID: PMC5484213 DOI: 10.1097/md.0000000000007196] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/17/2022] Open
Abstract
RATIONALE BRAF and MEK inhibitors have significantly improved the prognosis of metastatic melanoma, by inhibiting both the mitogen-activated protein kinase (MAP-kinase) pathway. They are associated with infrequent adverse kidney events. Most of these are related to the use of BRAF inhibitors and involve interstitial nephritis with acute tubular necrosis. PATIENT CONCERNS We report a unique case of glomerulonephritis with renal granulomatous vasculitis in a patient diagnosed with metastatic melanoma treated with BRAF and MEK inhibitors. The patient was a 55-year old woman, who presented a melanoma of the right thigh with pulmonary metastasis. Treatment started in November 2015, with Encorafenib and Binimetinib, new BRAF and MEK inhibitors, respectively. Two months after the beginning of the treatment, there was a worsening of her renal function with significant proteinuria. DIAGNOSES Kidney biopsy showed extracapillary proliferation in the glomeruli with a granulomatous reaction. INTERVENTIONS AND OUTCOMES Renal function recovered completely after withdrawal of the chemotherapy. LESSONS All the reported kidney adverse events secondary to BRAF and MEK inhibitors in the literature are related to the use of BRAF inhibitors. Some previous reported mechanistic investigations also provide insight between BRAF inhibitors and podocytes injuries. Therefore, encorafenib most likely is the main responsible of the disease. However, evidence has emerged that inhibition of the MAP kinase pathway could also enhance autoimmunity. Thus, binimetinib may also have played a role and the combination of BRAF and MEK inhibitors may have facilitated this autoimmune kidney disease.
Collapse
Affiliation(s)
- Mehdi Maanaoui
- Department of Nephrology, CHU Lille, University of Lille, Lille, France
| | | | - Viviane Gnemmi
- Department of Pathology, University of Lille, Inserm, CHU Lille, UMR-S 1172 – JPARC – Jean-Pierre Aubert Research Center, Lille, France
| | - Marie Frimat
- Department of Nephrology, CHU Lille, University of Lille, Lille, France
| | - Arnaud Lionet
- Department of Nephrology, CHU Lille, University of Lille, Lille, France
| | - Marc Hazzan
- Department of Nephrology, CHU Lille, University of Lille, Lille, France
| | - Christian Noël
- Department of Nephrology, CHU Lille, University of Lille, Lille, France
| | - François Provot
- Department of Nephrology, CHU Lille, University of Lille, Lille, France
| |
Collapse
|
23
|
Thilly N, Chanliau J, Frimat L, Combe C, Merville P, Chauveau P, Bataille P, Azar R, Laplaud D, Noël C, Kessler M. Cost-effectiveness of home telemonitoring in chronic kidney disease patients at different stages by a pragmatic randomized controlled trial (eNephro): rationale and study design. BMC Nephrol 2017; 18:126. [PMID: 28381266 PMCID: PMC5381043 DOI: 10.1186/s12882-017-0529-2] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2016] [Accepted: 03/23/2017] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Home telemonitoring has developed considerably over recent years in chronic diseases in order to improve communication between healthcare professionals and patients and to promote early detection of deteriorating health status. In the nephrology setting, home telemonitoring has been evaluated in home dialysis patients but data are scarce concerning chronic kidney disease (CKD) patients before and after renal replacement therapy. The eNephro study is designed to assess the cost effectiveness, clinical/biological impact, and patient perception of a home telemonitoring for CKD patients. Our purpose is to present the rationale, design and organisational aspects of this study. METHODS eNephro is a pragmatic randomised controlled trial, comparing home telemonitoring versus usual care in three populations of CKD patients: stage 3B/4 (n = 320); stage 5D CKD on dialysis (n = 260); stage 5 T CKD treated with transplantation (n= 260). Five hospitals and three not-for-profit providers managing self-care dialysis situated in three administrative regions in France are participating. The trial began in December 2015, with a scheduled 12-month inclusion period and 12 months follow-up. Outcomes include clinical and biological data (e.g. blood pressure, haemoglobin) collected from patient records, perceived health status (e.g. health related quality of life) collected from self-administered questionnaires, and health expenditure data retrieved from the French health insurance database (SNIIRAM) using a probabilistic matching procedure. DISCUSSION The hypothesis is that home telemonitoring enables better control of clinical and biological parameters as well as improved perceived health status. This better control should limit emergency consultations and hospitalisations leading to decreased healthcare expenditure, compensating for the financial investment due to the telemedicine system. TRIAL REGISTRATION This study has been registered at ClinicalTrials.gov under NCT02082093 (date of registration: February 14, 2014).
Collapse
Affiliation(s)
- Nathalie Thilly
- CHRU de Nancy, Plateforme d'Aide à la Recherche Clinique, Nancy, France. .,EA 4360 APEMAC, Université de Lorraine, 54511, Vandoeuvre-lès-Nancy Cedex, Nancy, France.
| | - Jacques Chanliau
- Association Lorraine pour le Traitement de l'Insuffisance Rénale (ALTIR), Nancy, France
| | - Luc Frimat
- EA 4360 APEMAC, Université de Lorraine, 54511, Vandoeuvre-lès-Nancy Cedex, Nancy, France.,CHRU de Nancy, Service de Néphrologie, Nancy, France
| | - Christian Combe
- CHU de Bordeaux, Service de Néphrologie Transplantation Dialyse, Bordeaux, France.,Université Bordeaux Segalen, Inserm U1026, Bordeaux, France
| | - Pierre Merville
- CHU de Bordeaux, Service de Néphrologie Transplantation Dialyse, Bordeaux, France.,Université Bordeaux Segalen, CNRS UMR5164, Bordeaux, France
| | - Philippe Chauveau
- CHU de Bordeaux, Service de Néphrologie Transplantation Dialyse, Bordeaux, France.,Université Bordeaux Segalen, Inserm U889, Bordeaux, France
| | - Pierre Bataille
- CH de Boulogne sur Mer, Service de Néphrologie, Boulogne sur Mer, France
| | - Raymond Azar
- CH de Dunkerque, Service de Néphrologie, Dunkerque, France
| | | | | | | |
Collapse
|
24
|
Ghisdal L, Baron C, Lebranchu Y, Viklický O, Konarikova A, Naesens M, Kuypers D, Dinic M, Alamartine E, Touchard G, Antoine T, Essig M, Rerolle JP, Merville P, Taupin JL, Le Meur Y, Grall‐Jezequel A, Glowacki F, Noël C, Legendre C, Anglicheau D, Broeders N, Coppieters W, Docampo E, Georges M, Ajarchouh Z, Massart A, Racapé J, Abramowicz D, Abramowicz M. Genome-Wide Association Study of Acute Renal Graft Rejection. Am J Transplant 2017; 17:201-209. [PMID: 27272414 PMCID: PMC5215306 DOI: 10.1111/ajt.13912] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2016] [Revised: 04/29/2016] [Accepted: 05/23/2016] [Indexed: 01/25/2023]
Abstract
Acute renal rejection is a major risk factor for chronic allograft dysfunction and long-term graft loss. We performed a genome-wide association study to detect loci associated with biopsy-proven acute T cell-mediated rejection occurring in the first year after renal transplantation. In a discovery cohort of 4127 European renal allograft recipients transplanted in eight European centers, we used a DNA pooling approach to compare 275 cases and 503 controls. In an independent replication cohort of 2765 patients transplanted in two European countries, we identified 313 cases and 531 controls, in whom we genotyped individually the most significant single nucleotide polymorphisms (SNPs) from the discovery cohort. In the discovery cohort, we found five candidate loci tagged by a number of contiguous SNPs (more than five) that was never reached in iterative in silico permutations of our experimental data. In the replication cohort, two loci remained significantly associated with acute rejection in both univariate and multivariate analysis. One locus encompasses PTPRO, coding for a receptor-type tyrosine kinase essential for B cell receptor signaling. The other locus involves ciliary gene CCDC67, in line with the emerging concept of a shared building design between the immune synapse and the primary cilium.
Collapse
Affiliation(s)
- L. Ghisdal
- Department of Nephrology, Dialysis, and TransplantationHôpital Erasme (Université Libre de Bruxelles)BrusselsBelgium,Present address: Department of NephrologyCentre Hospitalier EpiCURABaudourBelgium
| | - C. Baron
- Department of NephrologyCentre Hospitalier Régional Universitaire de ToursToursFrance
| | - Y. Lebranchu
- Department of NephrologyCentre Hospitalier Régional Universitaire de ToursToursFrance
| | - O. Viklický
- Department of NephrologyTransplant CentreInstitute for Clinical and Experimental MedicinePragueCzech Republic
| | - A. Konarikova
- Department of NephrologyTransplant CentreInstitute for Clinical and Experimental MedicinePragueCzech Republic
| | - M. Naesens
- Department of Microbiology and ImmunologyKU LeuvenUniversity of LeuvenLeuvenBelgium,Department of NephrologyUniversity Hospitals LeuvenLeuvenBelgium
| | - D. Kuypers
- Department of Microbiology and ImmunologyKU LeuvenUniversity of LeuvenLeuvenBelgium,Department of NephrologyUniversity Hospitals LeuvenLeuvenBelgium
| | - M. Dinic
- Department of NephrologyCentre Hospitalier Universitaire de Saint‐EtienneSaint‐EtienneFrance
| | - E. Alamartine
- Department of NephrologyCentre Hospitalier Universitaire de Saint‐EtienneSaint‐EtienneFrance
| | - G. Touchard
- Department of NephrologyCentre Hospitalier Universitaire de PoitiersPoitiersFrance
| | - T. Antoine
- Department of NephrologyCentre Hospitalier Universitaire de PoitiersPoitiersFrance
| | - M. Essig
- Department of Nephrology, Dialysis, TransplantationCentre Hospitalier Universitaire de Limoges and INSERM UMR 850 (Université de Limoges)LimogesFrance
| | - J. P. Rerolle
- Department of Nephrology, Dialysis, TransplantationCentre Hospitalier Universitaire de Limoges and INSERM UMR 850 (Université de Limoges)LimogesFrance
| | - P. Merville
- Department of NephrologyCentre Hospitalier Universitaire de BordeauxBordeauxFrance
| | - J. L. Taupin
- Department of Immunology and HistocompatibilityHôpital Saint‐LouisParisFrance
| | - Y. Le Meur
- Department of NephrologyCentre Hospitalier Universitaire la Cavale blancheBrestFrance
| | - A. Grall‐Jezequel
- Department of NephrologyCentre Hospitalier Universitaire la Cavale blancheBrestFrance
| | - F. Glowacki
- Department of NephrologyCentre Régional Hospitalier Universitaire de LilleLilleFrance
| | - C. Noël
- Department of NephrologyCentre Régional Hospitalier Universitaire de LilleLilleFrance
| | - C. Legendre
- Department of Renal TransplantationUniversité Paris Descartes and Hôpital NeckerAssistance Publique‐Hôpitaux de ParisParisFrance
| | - D. Anglicheau
- Department of Renal TransplantationUniversité Paris Descartes and Hôpital NeckerAssistance Publique‐Hôpitaux de ParisParisFrance
| | - N. Broeders
- Department of Nephrology, Dialysis, and TransplantationHôpital Erasme (Université Libre de Bruxelles)BrusselsBelgium
| | - W. Coppieters
- Unit of Animal GenomicsGroupe Interdisciplinaire de Génoprotéomique Appliquée‐Research (GIGA‐R)University of LiègeLiègeBelgium
| | - E. Docampo
- Unit of Animal GenomicsGroupe Interdisciplinaire de Génoprotéomique Appliquée‐Research (GIGA‐R)University of LiègeLiègeBelgium
| | - M. Georges
- Unit of Animal GenomicsGroupe Interdisciplinaire de Génoprotéomique Appliquée‐Research (GIGA‐R)University of LiègeLiègeBelgium
| | - Z. Ajarchouh
- Institute of Interdisciplinary Research in Molecular and Human biology (IRIBHM)Université Libre de BruxellesBrusselsBelgium
| | - A. Massart
- Department of Nephrology, Dialysis, and TransplantationHôpital Erasme (Université Libre de Bruxelles)BrusselsBelgium,Institute of Interdisciplinary Research in Molecular and Human biology (IRIBHM)Université Libre de BruxellesBrusselsBelgium
| | - J. Racapé
- Centre of EpidemiologyBiostatistic and Clinical ResearchSchool of Public Health (Université Libre de Bruxelles)BrusselsBelgium
| | - D. Abramowicz
- Department of Nephrology, Dialysis, and TransplantationHôpital Erasme (Université Libre de Bruxelles)BrusselsBelgium,Department of NephrologyAntwerp University HospitalAntwerpenBelgium
| | - M. Abramowicz
- Institute of Interdisciplinary Research in Molecular and Human biology (IRIBHM)Université Libre de BruxellesBrusselsBelgium,Medical Genetics DepartmentHôpital Erasme (Université Libre de Bruxelles)BrusselsBelgium
| |
Collapse
|
25
|
Belaiche S, Mercier E, Cuny D, Kambia N, Wierre P, Bertoux É, Mascaut D, Azar R, Bataille P, Bourdon F, Mac Namara É, Maisonneuve N, Painchart B, Vrigneau L, Noël C, Décaudin B, Glowacki F. [Community pharmacists' interventions to prevent and screen chronic kidney disease patients]. Nephrol Ther 2016; 13:87-92. [PMID: 27810277 DOI: 10.1016/j.nephro.2016.06.006] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2016] [Revised: 05/20/2016] [Accepted: 06/28/2016] [Indexed: 02/08/2023]
Abstract
Chronic kidney disease (CKD) is a major concern of public health. The pharmacist is known as a health practitioner involved in prevention and therapeutic education. Our study aimed at defining the impact of community pharmacists' interventions for preventing and screening CKD. In our observational prospective study of 5 months conducted in 109 community pharmacy, we included 2 groups of patients: A (therapeutic optimization): CKD patients and B (CKD screening): population at risk. In group A, we included 354 patients, mainly women (51.2%), in stage 3 of CKD, mean age 73 years old, with hypertension alone (40.6%) or associated with diabetes (44%). About 70% of the patients had a follow up by a nephrologist and 45% of them were good adherent according to the Morisky-Green self-report. However, approximately 20% of patients did not have nephroprotective treatments in their regimen although they were on stage 3 or 4 CKD patients, and about half of them were not aware of medical situations at risk. Concerning group B, 532 patients were included. The pharmaceutical interventions screened 10% of patients with a GFR<60mL/min/1.73m2. The community pharmacists' interventions helped to optimize the therapeutic management of CKD patients and in the early screening of patients at risk. More studies are needed to extrapolate our observations to a larger population.
Collapse
Affiliation(s)
- Stéphanie Belaiche
- Institut de pharmacie, CHRU de Lille, rue Philippe-Marrache, 59000 Lille, France; EA 7365, groupe de recherche sur les formes injectables et les technologies associées (GRITA), université de Lille, 59000 Lille, France.
| | - Edwige Mercier
- Institut de pharmacie, CHRU de Lille, rue Philippe-Marrache, 59000 Lille, France
| | - Damien Cuny
- EA 4483, impact de l'environnement chimique sur la santé humaine (IMPECS), université de Lille, 59000 Lille, France
| | - Nicolas Kambia
- EA 7365, groupe de recherche sur les formes injectables et les technologies associées (GRITA), université de Lille, 59000 Lille, France
| | - Patrick Wierre
- Faculté de pharmacie, université de Lille, 59000 Lille, France
| | | | - Daniel Mascaut
- Faculté de pharmacie, université de Lille, 59000 Lille, France
| | - Raymond Azar
- Service de néphrologie, centre hospitalier de Dunkerque, 59240 Dunkerque, France
| | - Pierre Bataille
- Service de néphrologie, centre hospitalier de Boulogne-sur-Mer, 62200 Boulogne-sur-Mer, France
| | | | - Évelyne Mac Namara
- Service de néphrologie, centre hospitalier de Béthune, 62131 Béthune, France
| | - Nathalie Maisonneuve
- Service de néphrologie-dialyse, centre hospitalier de Valenciennes, 59322 Valenciennes, France
| | - Bernard Painchart
- Service de néphrologie, centre hospitalier de Cambrai, 59400 Cambrai, France
| | - Laurence Vrigneau
- Service de néphrologie-dialyse, centre hospitalier de Valenciennes, 59322 Valenciennes, France
| | - Christian Noël
- Service de néphrologie, CHRU de Lille, 59000 Lille, France; Lille inflammation research international center (LIRIC), Inserm U995, université de Lille, 59000 Lille, France
| | - Bertrand Décaudin
- Institut de pharmacie, CHRU de Lille, rue Philippe-Marrache, 59000 Lille, France; EA 7365, groupe de recherche sur les formes injectables et les technologies associées (GRITA), université de Lille, 59000 Lille, France
| | - François Glowacki
- EA 4483, impact de l'environnement chimique sur la santé humaine (IMPECS), université de Lille, 59000 Lille, France; Service de néphrologie, CHRU de Lille, 59000 Lille, France
| | -
- Réseau Néphronor, CHRU de Lille, 59000 Lille, France
| |
Collapse
|
26
|
Tabibzadeh N, Glowacki F, Frimat M, Elsermans V, Provôt F, Lionet A, Gnemmi V, Hertig A, Noël C, Hazzan M. Long-term outcome after early cyclosporine withdrawal in kidney transplantation: ten years after. Clin Transplant 2016; 30:1480-1487. [DOI: 10.1111/ctr.12843] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/07/2016] [Indexed: 11/29/2022]
Affiliation(s)
- Nahid Tabibzadeh
- CHU Lille - Service de Néphrologie - F-59000 Lille France
- Université de Lille - UMR 995, F-59000 Lille France
| | - François Glowacki
- CHU Lille - Service de Néphrologie - F-59000 Lille France
- Université de Lille - UMR 995, F-59000 Lille France
| | - Marie Frimat
- CHU Lille - Service de Néphrologie - F-59000 Lille France
- Université de Lille - UMR 995, F-59000 Lille France
| | - Vincent Elsermans
- Université de Lille - UMR 995, F-59000 Lille France
- CHU Lille - Laboratoire d'Immunologie - F-59000 Lille France
| | | | - Arnaud Lionet
- CHU Lille - Service de Néphrologie - F-59000 Lille France
| | - Viviane Gnemmi
- Université de Lille - UMR 995, F-59000 Lille France
- CHU Lille - Laboratoire d'Anatomopathologie - F-59000 Lille France
| | - Alexandre Hertig
- Urgences Néphrologiques et Transplantation Rénale; Hôpital Tenon, APHP; Paris France
- UPMC Sorbonne Université Paris 06, UMR S 1155, F-75020; Paris France
| | - Christian Noël
- CHU Lille - Service de Néphrologie - F-59000 Lille France
- Université de Lille - UMR 995, F-59000 Lille France
| | - Marc Hazzan
- CHU Lille - Service de Néphrologie - F-59000 Lille France
- Université de Lille - UMR 995, F-59000 Lille France
| |
Collapse
|
27
|
Aureli R, Ueberschlag Q, Klein F, Noël C, Guggenbuhl P. Use of near infrared reflectance spectroscopy to predict phytate phosphorus, total phosphorus, and crude protein of common poultry feed ingredients. Poult Sci 2016; 96:160-168. [PMID: 27433015 DOI: 10.3382/ps/pew214] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Revised: 11/19/2015] [Accepted: 06/01/2016] [Indexed: 01/10/2023] Open
Abstract
The purpose of the study that is presented herein was to develop near-infrared reflectance spectroscopy (NIRS) calibrations to predict total phosphorus (P), phytate-P, and protein concentrations of feed ingredients commonly used in monogastric feed formulation. Samples representing 14 vegetable ingredients (cereals, cereal by-products, and oilseed meals) were collected worldwide throughout 2013. The samples were assayed by standard wet chemical techniques for total P, phytate-P, and protein content. There was substantial variability in protein, phytate-P, and total P within and between ingredients used in the calibration set. Protein content varied from 76 to 487 g/kg. Total P ranged from 2.09 and 22.5 g/kg and phytate-P ranged from 0.99 and 13.8 g/kg. Within these broad ranges, NIRS values were highly correlated for determination of protein, total P, and phytate-P with a standard error of prediction equal to 9.06 g/kg, 0.80 g/kg, and 0.66 g/kg, respectively. The wide diversity and heterogeneity of the mix of feed ingredients allowed the development of NIRS calibrations of sufficient accuracy to help nutritionists control the nutritional composition of their feed.
Collapse
Affiliation(s)
- R Aureli
- Research Center for Animal Nutrition and Health, DSM Nutritional Products, F-68128, Village-Neuf, France
| | - Q Ueberschlag
- Research Center for Animal Nutrition and Health, DSM Nutritional Products, F-68128, Village-Neuf, France
| | - F Klein
- Research Center for Animal Nutrition and Health, DSM Nutritional Products, F-68128, Village-Neuf, France
| | - C Noël
- Research Center for Animal Nutrition and Health, DSM Nutritional Products, F-68128, Village-Neuf, France
| | - P Guggenbuhl
- Research Center for Animal Nutrition and Health, DSM Nutritional Products, F-68128, Village-Neuf, France
| |
Collapse
|
28
|
Hennino MF, Buob D, Van der Hauwaert C, Gnemmi V, Jomaa Z, Pottier N, Savary G, Drumez E, Noël C, Cauffiez C, Glowacki F. miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy. Sci Rep 2016; 6:27209. [PMID: 27264483 PMCID: PMC4893709 DOI: 10.1038/srep27209] [Citation(s) in RCA: 60] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2016] [Accepted: 05/11/2016] [Indexed: 12/24/2022] Open
Abstract
IgA nephropathy (IgAN) is the most prevalent primary glomerulonephritis, whose prognosis is highly variable. Interstitial fibrosis is a strong independent prognosis factor. Among microRNA involved in renal fibrogenesis, only few have been investigated in IgAN. In the context of IgAN, we aimed to analyze the role of miR-21-5p, miR-214-3p and miR-199a-5p, three established "fibromiRs" involved in renal fibrosis. Fifty-six IgAN biopsy specimens were retrospectively scored according to Oxford classification. Renal expression of miR-21-5p, miR-214-3p and miR-199a-5p were significantly associated with T score (miR-21-5p T0 RQ median = 1.23, T1 RQ = 3.01, T2 RQ = 3.90; miR-214-5p T0 RQ = 1.39, T1 RQ = 2.20, T2 RQ = 2.48; miR-199a-5p T0 RQ = 0.76, T1 RQ = 1.41, T2 RQ = 1.87). miR-21-5p expression was associated with S score (S0 RQ median = 1.31, S1 RQ = 2.65), but not miR-214-3p nor miR-199a-5p. In our cohort, poor renal survival was associated with high blood pressure, proteinuria and elevated creatininemia, as well as T and S scores. Moreover, renal expression of miR-21-5p, miR-214-3p were associated with renal survival. In conclusion, miR-21-5p, miR-214-3p and miR-199a-5p are three "fibromiRs" involved in renal fibrosis in the course of IgAN and miR-21-5p and miR-214-3p are associated with renal survival.
Collapse
Affiliation(s)
- Marie-Flore Hennino
- Univ. Lille, CHU Lille - Service de néphrologie, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact of Environmental ChemicalS on human health, F-59000 Lille, France.,Centre Hospitalier de Valenciennes - Service de néphrologie, médecine interne et vasculaire, F-59300 Valenciennes, France
| | - David Buob
- Sorbonne Universités, UPMC Paris 06, Inserm, AP-HP, Hôpital Tenon, Pathology Department, UMR S 1155, F-75020 Paris, France
| | - Cynthia Van der Hauwaert
- Univ. Lille, CHU Lille - Service de néphrologie, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact of Environmental ChemicalS on human health, F-59000 Lille, France
| | - Viviane Gnemmi
- Univ. Lille, Inserm, CHU Lille, UMR-S 1172 - JPArc - Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer, F-59000 Lille, France
| | - Zacharie Jomaa
- Centre Hospitalier de Cambrai - Service de néphrologie, F-59400 Cambrai, France
| | - Nicolas Pottier
- Univ. Lille, CHU Lille - Service de néphrologie, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact of Environmental ChemicalS on human health, F-59000 Lille, France
| | - Grégoire Savary
- Univ. Lille, CHU Lille - Service de néphrologie, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact of Environmental ChemicalS on human health, F-59000 Lille, France
| | - Elodie Drumez
- Univ. Lille, CHU Lille, EA 2694 - Santé publique: épidémiologie et qualité des soins, F-59000 Lille, France
| | - Christian Noël
- Univ. Lille, Inserm, CHU Lille - Service de néphrologie, U995 - LIRIC - Lille Inflammation Research International Center, F-59000 Lille, France
| | - Christelle Cauffiez
- Univ. Lille, CHU Lille - Service de néphrologie, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact of Environmental ChemicalS on human health, F-59000 Lille, France
| | - François Glowacki
- Univ. Lille, CHU Lille - Service de néphrologie, Institut Pasteur de Lille, EA 4483 - IMPECS - IMPact of Environmental ChemicalS on human health, F-59000 Lille, France
| |
Collapse
|
29
|
Massart A, Pallier A, Pascual J, Viklicky O, Budde K, Spasovski G, Klinger M, Sever MS, Sørensen SS, Hadaya K, Oberbauer R, Dudley C, De Fijter JW, Yussim A, Hazzan M, Wekerle T, Berglund D, De Biase C, Pérez-Sáez MJ, Mühlfeld A, Orlando G, Clemente K, Lai Q, Pisani F, Kandus A, Baas M, Bemelman F, Ponikvar JB, Mazouz H, Stratta P, Subra JF, Villemain F, Hoitsma A, Braun L, Cantarell MC, Colak H, Courtney A, Frasca GM, Howse M, Naesens M, Reischig T, Serón D, Seyahi N, Tugmen C, Alonso Hernandez A, Beňa L, Biancone L, Cuna V, Díaz-Corte C, Dufay A, Gaasbeek A, Garnier A, Gatault P, Gentil Govantes MA, Glowacki F, Gross O, Hurault de Ligny B, Huynh-Do U, Janbon B, Jiménez del Cerro LA, Keller F, La Manna G, Lauzurica R, Le Monies De Sagazan H, Thaiss F, Legendre C, Martin S, Moal MC, Noël C, Pillebout E, Piredda GB, Puga AR, Sulowicz W, Tuglular S, Prokopova M, Chesneau M, Le Moine A, Guérif P, Soulillou JP, Abramowicz M, Giral M, Racapé J, Maggiore U, Brouard S, Abramowicz D. The DESCARTES-Nantes survey of kidney transplant recipients displaying clinical operational tolerance identifies 35 new tolerant patients and 34 almost tolerant patients. Nephrol Dial Transplant 2016; 31:1002-13. [DOI: 10.1093/ndt/gfv437] [Citation(s) in RCA: 35] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2015] [Accepted: 11/29/2015] [Indexed: 11/14/2022] Open
|
30
|
Jaillard A, Baillet C, Béron A, Tabibzadeh N, Scherpereel A, Frimat M, Perbet R, Gnemmi V, Noël C, Huglo D. FDG PET/CT allowing detection and follow-up of tumor cell transplantation. Ann Nucl Med 2015; 30:250-4. [PMID: 26681195 DOI: 10.1007/s12149-015-1051-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2015] [Accepted: 12/01/2015] [Indexed: 12/23/2022]
Abstract
After detection of small cell lung cancer in a 67-year-old patient who had donated a kidney 7 months earlier, the graft recipient underwent FDG-PET/CT to determine the presence/absence of tumor cell transmission. It showed abnormal increased uptake of the renal graft, associated with hypermetabolic lymph nodes and hepatic, pulmonary and bone lesions. Emergency graft resection was performed 5 days after PET/CT, permitting immunosuppressive therapy withdrawal. Pathologic examination of the kidney showed parenchymal infiltration by tumor cells compatible with small cell lung cancer. Thereafter, pathologists proved that the recipient's and donor's tumor cells matched using microsatellite markers. FDG-PET/CT was performed in the follow-up and showed progression in the donor despite chemotherapy and radiotherapy. He died a few months later. However, FDG-PET/CT showed a complete metabolic response after only 3 courses of chemotherapy in the recipient.
Collapse
Affiliation(s)
- Alice Jaillard
- CHU of Lille, Department of Nuclear Medicine, Hôpital Claude Huriez, 2 Avenue Oscar Lambret, 59000, Lille, France.
| | - Clio Baillet
- CHU of Lille, Department of Nuclear Medicine, Hôpital Claude Huriez, 2 Avenue Oscar Lambret, 59000, Lille, France
| | - Amandine Béron
- CHU of Lille, Department of Nuclear Medicine, Hôpital Claude Huriez, 2 Avenue Oscar Lambret, 59000, Lille, France
| | - Nahid Tabibzadeh
- CHU of Lille, Department of Nephrology, Hôpital Claude Huriez, 2 Avenue Oscar Lambret, 59000, Lille, France
| | - Arnaud Scherpereel
- CHU of Lille, Department of Pulmonary and Thoracic Oncology, Hôpital Albert Calmette, 2 Avenue Oscar Lambret, 59000, Lille, France.,Université de Lille, Faculté de Médecine, Place de Verdun, 59000, Lille, France
| | - Marie Frimat
- CHU of Lille, Department of Nephrology, Hôpital Claude Huriez, 2 Avenue Oscar Lambret, 59000, Lille, France
| | - Romain Perbet
- CHU of Lille, Department of Anatomopathology, Hôpital Claude Huriez, 2 Avenue Oscar Lambret, 59000, Lille, France
| | - Vivianne Gnemmi
- CHU of Lille, Department of Anatomopathology, Hôpital Claude Huriez, 2 Avenue Oscar Lambret, 59000, Lille, France
| | - Christian Noël
- CHU of Lille, Department of Nephrology, Hôpital Claude Huriez, 2 Avenue Oscar Lambret, 59000, Lille, France.,Université de Lille, Faculté de Médecine, Place de Verdun, 59000, Lille, France
| | - Damien Huglo
- CHU of Lille, Department of Nuclear Medicine, Hôpital Claude Huriez, 2 Avenue Oscar Lambret, 59000, Lille, France.,Université de Lille, Faculté de Médecine, Place de Verdun, 59000, Lille, France
| |
Collapse
|
31
|
Delattre V, Lionet A, Provot F, Lebas C, Frimat M, Lessore De Sainte Foy C, Glowacki F, Hazzan M, Noël C. Tolérance de 1000 séances de plasmaphérèses selon l’indication, l’abord vasculaire et la technique utilisée. Nephrol Ther 2015. [DOI: 10.1016/j.nephro.2015.07.409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
32
|
Ulrich M, Frimat M, Titcat M, Jacobsoone-Ulrich A, El Fallah S, Vandenbussche C, Lemoine C, Lionet A, Wallet F, Lebas C, Hazzan M, Noël C. Nocardiose disséminée en transplantation rénale : intérêt des β-d-glucanes. Nephrol Ther 2015. [DOI: 10.1016/j.nephro.2015.07.437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
33
|
Hellemans R, Hazzan M, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Merville P, Ouali N, Squifflet JP, Bayle F, Wissing KM, Noël C, Abramowicz D. Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study. Am J Transplant 2015; 15:1923-32. [PMID: 25707875 DOI: 10.1111/ajt.13191] [Citation(s) in RCA: 46] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2014] [Revised: 12/07/2014] [Accepted: 12/24/2014] [Indexed: 01/25/2023]
Abstract
We previously reported a randomized controlled trial in which 227 de novo deceased-donor kidney transplant recipients were randomized to rabbit antithymocyte (rATG, Thymoglobulin) or daclizumab if they were considered to be at high immunological risk, defined as high panel reactive antibodies (PRA), loss of a first kidney graft through rejection within 2 years of transplantation, or third or fourth transplantation. Patients treated with rATG had lower incidences of biopsy-proven acute rejection (BPAR) and steroid-resistant rejection at 1 year. Patients were followed to 5 years posttransplant in an observational study; findings are described here. Treatment with rATG was associated with a lower rate of BPAR at 5 years (14.2% vs. 26.0% with daclizumab; p = 0.035). Only one rATG-treated patient (0.9%) and one daclizumab-treated patient (1.0%) developed BPAR after 1 year. Five-year graft and patient survival rates, and renal function, were similar between the two groups. Overall graft survival at 5 years was significantly higher in patients without BPAR (81.0% vs. 54.8%; p < 0.001). In conclusion, rATG is superior to daclizumab for the prevention of BPAR among high-immunological-risk renal transplant recipients. Overall graft survival at 5 years was approximately 70% with either induction therapy, which compares favorably to low-risk cohorts.
Collapse
Affiliation(s)
- R Hellemans
- Dienst Néphrologie, Universitair Ziekenhuis Antwerpen, Edegem, Belgium
| | - M Hazzan
- Service de N, é, phrologie, Hôpital, Lille, France
| | - D Durand
- Service de Néphrologie-HTA-Dialyse-Transplantation, CHU-Toulouse Rangueil, Toulouse, France
| | - G Mourad
- Département de Néphrologie et Transplantation, CHRU-Hôpital Lapeyronie, Montpellier, France
| | - P Lang
- Service de Néphrologie, Hôpital Henri Mondor, Créteil, France
| | - M Kessler
- Département de Néphrologie, Hôpital Universitaire de Nancy, Nancy, France
| | - B Charpentier
- Service de Néphrologie, CHRU de Bicêtre, Bicêtre, France
| | - G Touchard
- Service de Néphrologie-Transplantation, CHU de Poitiers, Hôpital Jean-Bernard, Poitiers, France
| | - F Berthoux
- Service de Néphrologie, CHRU-Hôpital Nord, Saint-Etienne, France
| | - P Merville
- Service de Néphrologie, Hôpital Pellegrin, Bordeaux, France
| | - N Ouali
- Service de Néphrologie A, Hôpital Tenon, Paris, France
| | - J-P Squifflet
- Cliniques Universitaires St Luc, Brussels, and Department of Abdominal Transplantation, CHU Sart Tilman, Liege, Belgium
| | - F Bayle
- Service de Néphrologie, CHU de Grenoble, Grenoble, France
| | - K M Wissing
- Dienst Nefrologie, Universitair Ziekenhuis Brussel, Brussels, Belgium
| | - C Noël
- Service de N, é, phrologie, Hôpital, Lille, France
| | - D Abramowicz
- Dienst Néphrologie, Universitair Ziekenhuis Antwerpen, Edegem, Belgium
| |
Collapse
|
34
|
Van der Hauwaert C, Savary G, Pinçon C, Gnemmi V, Noël C, Broly F, Labalette M, Perrais M, Pottier N, Glowacki F, Cauffiez C. Donor caveolin 1 (CAV1) genetic polymorphism influences graft function after renal transplantation. Fibrogenesis Tissue Repair 2015; 8:8. [PMID: 25945124 PMCID: PMC4419392 DOI: 10.1186/s13069-015-0025-x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/10/2015] [Accepted: 04/10/2015] [Indexed: 12/20/2022]
Abstract
Background Identification of the culprit genes underlying multifactorial diseases is one of the most important current challenges of molecular genetics. While recent advances in genomics research have accelerated the discovery of susceptibility genes, much remains to be learned about the functions of disease-associated genetic variants. Recently, Moore and co-workers identified, in the donor genome, an association between a common genetic variant (rs4730751) in the gene encoding caveolin-1 (CAV1), a major structural component of caveolae, and long-term allograft survival. Methods Four hundred seventy-five renal recipients consecutively transplanted were included in this study. Donor genomic DNA was extracted and used to genotype CAV1 rs4730751 Single Nucleotide Polymorphism. Results Patients receiving a graft carrying CAV1 rs4730751 AA genotype displayed a significant decrease in estimated glomerular filtration rate and a significant increase in serum creatinine in both univariate and multivariate analyzes. Moreover, patients receiving a graft with CAV1 AA genotype significantly developed more interstitial fibrosis lesions on systematic biopsies performed 3 months post-transplantation. Conclusions Genotyping of CAV1 may be relevant to identify patients at risk of adverse renal transplant outcome.
Collapse
Affiliation(s)
- Cynthia Van der Hauwaert
- EA4483, Département de Biochimie et Biologie Moléculaire, Faculté de Médecine, Pôle Recherche, Université de Lille, 1 place de Verdun, Lille Cedex, 59045 France
| | - Grégoire Savary
- EA4483, Département de Biochimie et Biologie Moléculaire, Faculté de Médecine, Pôle Recherche, Université de Lille, 1 place de Verdun, Lille Cedex, 59045 France
| | - Claire Pinçon
- Laboratoire de Biomathématiques, Faculté des Sciences Pharmaceutiques, Université de Lille, 3 rue du Professeur Laguesse - BP 83, 59006 Lille Cedex, France
| | - Viviane Gnemmi
- Institut de Pathologie, Centre de Biologie Pathologie Génétique, CHRU, Boulevard du Professeur Jules Leclercq, 59037 Lille Cedex, France
| | - Christian Noël
- Service de Néphrologie, Hôpital Huriez, CHRU, 2 avenue Oscar Lambret, 59037 Lille Cedex, France
| | - Franck Broly
- EA4483, Département de Biochimie et Biologie Moléculaire, Faculté de Médecine, Pôle Recherche, Université de Lille, 1 place de Verdun, Lille Cedex, 59045 France
| | - Myriam Labalette
- Service d'Immunologie, Centre de Biologie Pathologie Génétique, CHRU, Boulevard du Professeur Jules Leclercq, 59037 Lille Cedex, France
| | - Michaël Perrais
- Institut National de la Santé et de la Recherche Médicale, U837, Jean-Pierre Aubert Research Center, Equipe 5 "Mucines, Différenciation et Cancérogenèse Épithéliales", 1 place de Verdun, 59045 Lille Cedex, France
| | - Nicolas Pottier
- EA4483, Département de Biochimie et Biologie Moléculaire, Faculté de Médecine, Pôle Recherche, Université de Lille, 1 place de Verdun, Lille Cedex, 59045 France
| | - François Glowacki
- EA4483, Département de Biochimie et Biologie Moléculaire, Faculté de Médecine, Pôle Recherche, Université de Lille, 1 place de Verdun, Lille Cedex, 59045 France ; Service de Néphrologie, Hôpital Huriez, CHRU, 2 avenue Oscar Lambret, 59037 Lille Cedex, France
| | - Christelle Cauffiez
- EA4483, Département de Biochimie et Biologie Moléculaire, Faculté de Médecine, Pôle Recherche, Université de Lille, 1 place de Verdun, Lille Cedex, 59045 France
| |
Collapse
|
35
|
Ghisdal L, Baron C, Lebranchu Y, Viklický O, Konarikova A, Naesen M, Dinic M, Alamartine E, Touchard G, Thierry A, Essig M, Rerolle JP, Merville P, Taupin JL, Le Meur Y, Glowacki F, Noël C, Legendre C, Coppieter W, Do Campo E, Georges M, Massart A, Racapé J, Abramowicz D, Abramowicz M. SP007GENOME-WIDE ASSOCIATION STUDY IDENTIFIES NEW LOCI ASSOCIATED WITH ACUTE RENAL GRAFT REJECTION. Nephrol Dial Transplant 2015. [DOI: 10.1093/ndt/gfv187.07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
36
|
Prot-Bertoye C, Lebbah S, Daudon M, Tostivint I, Bataille P, Bridoux F, Brignon P, Choquenet C, Cochat P, Combe C, Conort P, Decramer S, Doré B, Dussol B, Essig M, Gaunez N, Joly D, Le Toquin-Bernard S, Méjean A, Meria P, Morin D, N'Guyen HV, Noël C, Normand M, Pietak M, Ronco P, Saussine C, Tsimaratos M, Friedlander G, Traxer O, Knebelmann B, Courbebaisse M. CKD and Its Risk Factors among Patients with Cystinuria. Clin J Am Soc Nephrol 2015; 10:842-51. [PMID: 25717071 DOI: 10.2215/cjn.06680714] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2014] [Accepted: 01/12/2015] [Indexed: 01/19/2023]
Abstract
BACKGROUND AND OBJECTIVES Cystinuria is an autosomal recessive disorder affecting renal cystine reabsorption; it causes 1% and 8% of stones in adults and children, respectively. This study aimed to determine epidemiologic and clinical characteristics as well as comorbidities among cystinuric patients, focusing on CKD and high BP. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS This retrospective study was conducted in France, and involved 47 adult and pediatric nephrology and urology centers from April 2010 to January 2012. Data were collected from 442 cystinuric patients. RESULTS Median age at onset of symptoms was 16.7 (minimum to maximum, 0.3-72.1) years and median diagnosis delay was 1.3 (0-45.7) years. Urinary alkalinization and cystine-binding thiol were prescribed for 88.8% and 52.2% of patients, respectively, and 81.8% had at least one urological procedure. Five patients (1.1%, n=4 men) had to be treated by dialysis at a median age of 35.0 years (11.8-70.7). Among the 314 patients aged ≥16 years, using the last available plasma creatinine, 22.5% had an eGFR≥90 ml/min per 1.73 m(2) (calculated by the Modification of Diet in Renal Disease equation), whereas 50.6%, 15.6%, 7.6%, 2.9%, and 0.6% had an eGFR of 60-89, 45-59, 30-44, 15-29, and <15, respectively. Among these 314 patients, 28.6% had high BP. In multivariate analysis, CKD was associated with age (odds ratio, 1.05 [95% confidence interval, 1.03 to 1.07]; P<0.001), hypertension (3.30 [1.54 to 7.10]; P=0.002), and severe damage of renal parenchyma defined as a past history of partial or total nephrectomy, a solitary congenital kidney, or at least one kidney with a size <10 cm in patients aged ≥16 years (4.39 [2.00 to 9.62]; P<0.001), whereas hypertension was associated with age (1.06 [1.04 to 1.08]; P<0.001), male sex (2.3 [1.3 to 4.1]; P=0.003), and an eGFR<60 ml/min per 1.73 m(2) (2.7 [1.5 to 5.1]; P=0.001). CONCLUSIONS CKD and high BP occur frequently in patients with cystinuria and should be routinely screened.
Collapse
Affiliation(s)
- Caroline Prot-Bertoye
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Saïd Lebbah
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Michel Daudon
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Isabelle Tostivint
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Pierre Bataille
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Franck Bridoux
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Pierre Brignon
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Christian Choquenet
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Pierre Cochat
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Christian Combe
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Pierre Conort
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Stéphane Decramer
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Bertrand Doré
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Bertrand Dussol
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Marie Essig
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Nicolas Gaunez
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Dominique Joly
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Sophie Le Toquin-Bernard
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Arnaud Méjean
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Paul Meria
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Denis Morin
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Hung Viet N'Guyen
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Christian Noël
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Michel Normand
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Michel Pietak
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Pierre Ronco
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Christian Saussine
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Michel Tsimaratos
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Gérard Friedlander
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Olivier Traxer
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Bertrand Knebelmann
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material
| | - Marie Courbebaisse
- Due to the number of contributing authors,the affiliations are provided in the Supplemental Material.
| | | |
Collapse
|
37
|
Bloch J, Hazzan M, Van der Hauwaert C, Buob D, Savary G, Hertig A, Gnemmi V, Frimat M, Perrais M, Copin MC, Broly F, Noël C, Pottier N, Cauffiez C, Glowacki F. Donor ABCB1 genetic polymorphisms influence epithelial-to-mesenchyme transition in tacrolimus-treated kidney recipients. Pharmacogenomics 2014; 15:2011-24. [DOI: 10.2217/pgs.14.146] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
Abstract
Aim: The contribution of epithelial–mesenchymal transition (EMT) has been suggested in renal transplant recipients receiving calcineurin inhibitors and developing nephrotoxicity. Materials & methods: We assessed whether interindividual variability in tacrolimus pharmacokinetics is associated with the occurrence in tubular cells of two EMT markers (vimentin, β-catenin) detected at 3‐month in 140 allograft biopsies. We investigated whether genetic polymorphisms affecting CYP3A5 and ABCB1 influence EMT and kidney fibrosis. Results: In univariate analysis, the donor CYP3A5*1 allele was significantly associated with a lower vimentin expression. In multivariate analysis, grafts carrying ABCB1 3435T allele(s) developed significantly less EMT and less interstitial fibrosis. Conclusion: Donor SNPs significantly influence the epithelial program in the context of kidney transplantation, and the epithelial metabolism of tacrolimus is one key to understand graft fibrogenesis.
Collapse
Affiliation(s)
- Julie Bloch
- EA4483, Faculté de Médecine H Warembourg, Pôle Recherche, Université de Lille, France
- Service de Néphrologie, Hôpital Huriez, CHRU, Lille, France
| | - Marc Hazzan
- Service de Néphrologie, Hôpital Huriez, CHRU, Lille, France
| | | | - David Buob
- Institut de Pathologie, Centre de Biologie Pathologie Génétique, CHRU, Lille, France
| | - Grégoire Savary
- EA4483, Faculté de Médecine H Warembourg, Pôle Recherche, Université de Lille, France
| | - Alexandre Hertig
- Urgences Néphrologiques et Transplantation Rénale, Hôpital Tenon, AP-HP, Paris, France
| | - Viviane Gnemmi
- Institut de Pathologie, Centre de Biologie Pathologie Génétique, CHRU, Lille, France
| | - Marie Frimat
- Service de Néphrologie, Hôpital Huriez, CHRU, Lille, France
| | - Michaël Perrais
- Institut National de la Santé et de la Recherche Médicale, U837, Jean-Pierre Aubert Research Center, Equipe 5 "Mucines, Différenciation et Cancérogenèse Épithéliales", Lille, France
| | - Marie-Christine Copin
- Institut de Pathologie, Centre de Biologie Pathologie Génétique, CHRU, Lille, France
| | - Franck Broly
- EA4483, Faculté de Médecine H Warembourg, Pôle Recherche, Université de Lille, France
| | - Christian Noël
- Service de Néphrologie, Hôpital Huriez, CHRU, Lille, France
| | - Nicolas Pottier
- EA4483, Faculté de Médecine H Warembourg, Pôle Recherche, Université de Lille, France
| | - Christelle Cauffiez
- EA4483, Faculté de Médecine H Warembourg, Pôle Recherche, Université de Lille, France
| | - François Glowacki
- EA4483, Faculté de Médecine H Warembourg, Pôle Recherche, Université de Lille, France
- Service de Néphrologie, Hôpital Huriez, CHRU, Lille, France
| |
Collapse
|
38
|
Occelli F, Deram A, Génin M, Noël C, Cuny D, Glowacki F. Mapping end-stage renal disease (ESRD): spatial variations on small area level in northern France, and association with deprivation. PLoS One 2014; 9:e110132. [PMID: 25365039 PMCID: PMC4217729 DOI: 10.1371/journal.pone.0110132] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2014] [Accepted: 09/17/2014] [Indexed: 01/04/2023] Open
Abstract
BACKGROUND Strong geographic variations in the incidence of end-stage renal disease (ESRD) are observed in developed countries. The reasons for these variations are unknown. They may reflect regional inequalities in the population's sociodemographic characteristics, related diseases, or medical practice patterns. In France, at the district level, the highest incidence rates have been found in the Nord-Pas-de-Calais region. This area, with a high population density and homogeneous healthcare provision, represents a geographic situation which is quite suitable for the study, over small areas, of spatial disparities in the incidence of ESRD, together with their correlation with a deprivation index and other risk factors. METHODS The Renal Epidemiology and Information Network is a national registry, which lists all ESRD patients in France. All cases included in the Nord-Pas-de-Calais registry between 2005 and 2011 were extracted. Adjusted and smoothed standardized incidence ratio (SIR) was calculated for each of the 170 cantons, thanks to a hierarchical Bayesian model. The correlation between ESRD incidence and deprivation was assessed using the quintiles of Townsend index. Relative risk (RR) and credible intervals (CI) were estimated for each quintile. RESULTS Significant spatial disparities in ESRD incidence were found within the Nord-Pas-de-Calais region. The sex- and age-adjusted, smoothed SIRs varied from 0.66 to 1.64. Although no correlation is found with diabetic or vascular nephropathy, the smoothed SIRs are correlated with the Townsend index (RR: 1.18, 95% CI [1.00-1.34] for Q2; 1.28, 95% CI [1.11-1.47] for Q3; 1.30, 95% CI [1.14-1.51] for Q4; 1.44, 95% CI [1.32-1.74] for Q5). CONCLUSION For the first time at this aggregation level in France, this study reveals significant geographic differences in ESRD incidence. Unlike the time of renal replacement care, deprivation is certainly a determinant in this phenomenon. This association is probably independent of the patients' financial ability to gain access to healthcare.
Collapse
Affiliation(s)
- Florent Occelli
- EA 4483, Université Lille Nord de France, Faculté de Pharmacie de Lille, Lille, France
| | - Annabelle Deram
- EA 4483, Université Lille Nord de France, Faculté de Pharmacie de Lille, Lille, France
- Faculté Ingénierie et Management de la Santé (ILIS), Loos, France
| | - Michaël Génin
- EA 2694, Université Lille Nord de France, Faculté de Médecine pôle Recherche, Lille, France
| | - Christian Noël
- Service de Néphrologie, Hopital Huriez, CHRU de Lille, Lille, France
- Réseau Néphronor, Hôpital Huriez, CHRU de Lille, Lille, France
| | - Damien Cuny
- EA 4483, Université Lille Nord de France, Faculté de Pharmacie de Lille, Lille, France
| | - François Glowacki
- EA 4483, Université Lille Nord de France, Faculté de Pharmacie de Lille, Lille, France
- Service de Néphrologie, Hopital Huriez, CHRU de Lille, Lille, France
- Réseau Néphronor, Hôpital Huriez, CHRU de Lille, Lille, France
| | | |
Collapse
|
39
|
Perche J, Bui Nguyen L, El Fallah S, Semjen E, Guyon T, Lessoré de Sainte Foy C, Noël C, Glowacki F. Polyangéite granulomateuse : une présentation atypique révélée par une atteinte pseudo-tumorale pulmonaire. Nephrol Ther 2014. [DOI: 10.1016/j.nephro.2014.07.165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
40
|
Garstka A, Haeck M, Gnemmi V, Lionet A, Frimat M, Bazin D, Haymann J, Daudon M, Noël C. Présence de cristaux sur les biopsies de greffons rénaux : fréquence, étiologie et pronostic. Nephrol Ther 2014. [DOI: 10.1016/j.nephro.2014.07.293] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
41
|
Hazzan M, Hellemans R, Durand D, Mourad G, Lang P, Kessler M, Charpentier B, Touchard G, Berthoux F, Wissing K, Noël C, Abramowicz D. Comparaison de l’induction par daclizumab ou thymoglobuline chez les patients à haut risque immunologique : résultats à 5ans de l’étude TAXI. Nephrol Ther 2014. [DOI: 10.1016/j.nephro.2014.07.364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
42
|
Dinic M, Ghisdal L, Racapé J, Thibaudin L, Gatault P, Essig M, Le Meur Y, Noël C, Touchard G, Merville P, Ajarchouh Z, Mariat C, Abramowicz M, Abramowicz D, Alamartine E. UMOD polymorphism rs12917707 is not associated with severe or stable IgA nephropathy in a large Caucasian cohort. BMC Nephrol 2014; 15:138. [PMID: 25163389 PMCID: PMC4236674 DOI: 10.1186/1471-2369-15-138] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2013] [Accepted: 05/22/2014] [Indexed: 01/12/2023] Open
Abstract
Background Genetic factors are suspected in the pathogenesis of IgA nephropathy, as well as in the course of IgA nephropathy progression towards end stage renal failure. UMOD polymorphism rs12917707 is known to associate with end stage renal failure of mixed aetiologies. Methods We tested a large cohort of Caucasian patients for association of rs12917707 with IgA nephropathy showing a benign, stable course and with IgA nephropathy that progressed toward end stage renal failure. Results No association was observed between either groups, and a non-significant trend was observed for more severe IgA nephropathy with the allele reported to protect against end stage renal failure of mixed aetiologies. Conclusion We conclude that UMOD is unlikely to play a role in IgA nephropathy pathogenesis nor progression to end stage renal failure, and suggest that UMOD effects are restricted to some causes of renal disease, e.g. diabetes or hypertension.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | - Eric Alamartine
- Nephrology-Renal Transplantation Department, CHU de Saint Etienne & EA3064, GIMAP, Université Jean Monnet, Saint Etienne 42055 Cedex 02, France.
| |
Collapse
|
43
|
Houssiau L, Noël C, Mine N, Jung KW, Min WJ, Moon DW. Investigation of Cs surface layer formation in Cs-SIMS with TOF-MEIS and SIMS. SURF INTERFACE ANAL 2014. [DOI: 10.1002/sia.5614] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- L. Houssiau
- Research Centre in Physics of Matter and Radiation; University of Namur; 61 rue de Bruxelles B 5000 Namur Belgium
| | - C. Noël
- Research Centre in Physics of Matter and Radiation; University of Namur; 61 rue de Bruxelles B 5000 Namur Belgium
| | - N. Mine
- Research Centre in Physics of Matter and Radiation; University of Namur; 61 rue de Bruxelles B 5000 Namur Belgium
| | - K. W. Jung
- Department of New Biology; DGIST; Sang-Ri 50-1 Dalseong Daegu 711-873 Korea
| | - W. J. Min
- K-MAC; Yongsan-Dong 554 Yuseong-Gu Daejeon 305-500 Korea
| | - D. W. Moon
- Department of New Biology; DGIST; Sang-Ri 50-1 Dalseong Daegu 711-873 Korea
| |
Collapse
|
44
|
Glowacki F, Zacharie J, Hennino M, Van Der Hauwaert C, Gnemmi V, Cauffiez C, Noël C, Copin M, Buob D. Intérêt pratique du score d’Oxford dans la néphropathie à dépots mésangiaux d’IgA ? Nephrol Ther 2013. [DOI: 10.1016/j.nephro.2013.07.044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
45
|
Decambron M, Lionet A, Ducloy A, Jourdain M, Lessoré de Sainte Foy C, Hazzan M, Provôt F, Lemaitre L, Noël C. Intérêt pronostique de l’IRM rénale en cas d’insuffisance rénale aiguë anurique du post-partum. Nephrol Ther 2013. [DOI: 10.1016/j.nephro.2013.07.078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
46
|
Buob D, Decambron M, Gnemmi V, Hoffmann M, Azar R, Mac Namara E, Noël C, Copin M, Glowacki F. La hyalinose segmentaire et focale avec collapsus du floculus (collapsing glomerulopathy) est fréquente au cours des microangiopathies thrombotiques du rein natif. Données anatomopathologiques et étude immuno-histochimique du phénotype podocytaire. Nephrol Ther 2013. [DOI: 10.1016/j.nephro.2013.07.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
47
|
Bloch J, Buob D, Provot F, Glowacki F, Copin MC, Lionet A, Noël C, Hazzan M. Intérêt de la biopsie systématique de greffon à trois mois après transplantation rénale. Nephrol Ther 2013. [DOI: 10.1016/j.nephro.2013.07.308] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
48
|
Lionet A, Garstka A, Douillard C, Ceballos-Picot I, Marcelli F, Frimat M, Lemaître L, Noël C. Cristallisation massive des voies excrétrices urinaires en réanimation. Nephrol Ther 2013. [DOI: 10.1016/j.nephro.2013.07.082] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
49
|
Decambron M, Moktefi A, Ducloy A, Jourdain M, Frimat M, Lionet A, Buob D, Brochériou I, Noël C, Hazzan M, Hertig A, Provôt F. Microangiopathie thrombotique du postpartum et acide tranexamique. Nephrol Ther 2013. [DOI: 10.1016/j.nephro.2013.07.152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
50
|
Abstract
Incarceration of the retroverted gravid uterus in the third trimester is a rare but distinctive diagnosis. Initial symptoms are more frequently urinary and digestive symptoms which became more acute at the third trimester. Severe abdominal pain associated with bleeding in early labor leads to make the diagnosis during an emergency cesarean section. However, the typical features of the clinical transvaginal exam and the abdominal ultrasound exam can confirm easily this diagnosis. We report two additional cases where Joël-Cohen incision for cesarean section was possible after manual reposition of the uterus. We discuss the diagnostic approach and the management regarding a literature review.
Collapse
Affiliation(s)
- T Bultez
- Service de gynécologie obstétrique, centre hospitalier René-Dubos, 6 avenue de l'Île-de-France, Cergy-Pontoise cedex, France.
| | | | | |
Collapse
|